These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36030347)

  • 1. Sex, gender, and subclinical hypertensiveorgan damage-heart.
    Cuspidi C; Gherbesi E; Sala C; Tadic M
    J Hum Hypertens; 2023 Aug; 37(8):626-633. PubMed ID: 36030347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.
    Miceli F; Presta V; Citoni B; Canichella F; Figliuzzi I; Ferrucci A; Volpe M; Tocci G
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1863-1871. PubMed ID: 31693279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and Organ Damage in Women.
    Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
    Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
    Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension.
    Wang T; Zhong H; Lian G; Cai X; Gong J; Ye C; Xie L
    Kidney Blood Press Res; 2019; 44(4):590-603. PubMed ID: 31387099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community.
    Vasan RS; Song RJ; Xanthakis V; Beiser A; DeCarli C; Mitchell GF; Seshadri S
    Hypertension; 2022 Mar; 79(3):505-515. PubMed ID: 35138872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction.
    Bertacchini F; Agabiti Rosei C; Buso G; Cappellini S; Stassaldi D; Aggiusti C; Salvetti M; Paini A; De Ciuceis C; Muiesan ML
    High Blood Press Cardiovasc Prev; 2022 Nov; 29(6):585-593. PubMed ID: 36352335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial strain and left ventricular geometry: a meta-analysis of echocardiographic studies in systemic hypertension.
    Tadic M; Sala C; Carugo S; Mancia G; Grassi G; Cuspidi C
    J Hypertens; 2021 Nov; 39(11):2297-2306. PubMed ID: 34128494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.
    Katz DH; Beussink L; Sauer AJ; Freed BH; Burke MA; Shah SJ
    Am J Cardiol; 2013 Oct; 112(8):1158-64. PubMed ID: 23810323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
    Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Structural to Functional Hypertension Mediated Target Organ Damage-A Long Way to Heart Failure with Preserved Ejection Fraction.
    Mancusi C; Lembo M; Manzi MV; Basile C; Fucile I; Morisco C
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and Functional Heart Abnormalities Associated to High Modified Tei Index in Hypertensive Patients.
    Tissera G; Piskorz D; Citta L; Citta N; Citta P; Keller L; Bongarzoni L; Mata L; Tommasi A
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):373-380. PubMed ID: 27623974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, hypertension, and tobacco use associated with left ventricular remodeling and hypertrophy in South African women: Birth to Twenty Plus Cohort.
    Kolkenbeck-Ruh A; Soepnel LM; Crouch SH; Naidoo S; Smith W; Norris SA; Davies J; Ware LJ
    BMC Cardiovasc Disord; 2022 Sep; 22(1):403. PubMed ID: 36085014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension-Mediated Organ Damage In Young Patients With First-Diagnosed And Never Treated Systolic Hypertension.
    Benas D; Triantafyllidi H; Birmpa D; Fambri A; Schoinas A; Thymis I; Kostelli G; Ikonomidis I
    Curr Vasc Pharmacol; 2023; 21(3):197-204. PubMed ID: 37533181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blood Pressure Control Level With Left Ventricular Morphology and Function and With Subclinical Cerebrovascular Disease.
    Nakanishi K; Jin Z; Homma S; Elkind MSV; Rundek T; Tugcu A; Sacco RL; Di Tullio MR
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28757483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
    Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
    Heart Vessels; 2020 Oct; 35(10):1446-1453. PubMed ID: 32430700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.